Author details

Full Name

Joanna Vermeij

Affiliation

Hospital Network Antwerp (ZNA)

ORCID

Career Start Year

1996

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35970014	PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.	ESMO Open	2022
34312396	Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.	NPJ Breast Cancer	2021
29092024	Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.	Ann Oncol	2018
30094075	Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer.	ESMO Open	2018
28258960	Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?	Clin Genitourin Cancer	2017
27032107	Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).	PLoS One	2016
26850781	Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program.	Urol Oncol	2016
18182111	Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers.	BMC Cancer	2008
18390417	[Targeted therapies in the treatment of non-small cell lung cancer].	Bull Cancer	2008
16739329	Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases.	Anticancer Res	2006
14585325	Restoration of an impaired TGF-beta1 autocrine growth-inhibitory circuit results in growth inhibition of ovarian epithelial cancer cells and complete inhibition of their tumorigenicity.	Cancer Detect Prev	2003
11509889	Characterization of permanent cell lines that contain the AAV2 rep-cap genes on an Epstein-Barr-virus-based episomal plasmid.	Intervirology	2001
11720450	Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector.	Br J Cancer	2001
11482895	Contaminants within bacterial plasmid preparations trigger apoptosis in liposome transfected OVCAR3, but not in SKOV3 or AZ224 human ovarian cancer cells.	Cell Biol Int	2001
8649827	Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium.	Oncogene	1996

1 - 15 of 15

Saravut J Weroha

Mayo Clinic

Career Start Year 2001

Number of shared co-authors 0

Iain A McNeish

Ovarian Cancer Action Research Centre, Imperial College London

Career Start Year 1996

Number of shared co-authors 2

James D Brenton

CRUK Cambridge Institute, University of Cambridge

Career Start Year 1995

Number of shared co-authors 4

Paul N Span

Radboud University Medical Center

Career Start Year 1993

Number of shared co-authors 6

Denise C Connolly

Fox Chase Cancer Center

Career Start Year 1993

Number of shared co-authors 0

Barry R Davies

Oncology R&D

Career Start Year 1992

Number of shared co-authors 0

Rosalind Glasspool

University of Glasgow

Career Start Year 1992

Number of shared co-authors 3

Anil K Sood

The University of Texas MD Anderson Cancer Center

Career Start Year 1991

Number of shared co-authors 0

Rosemarie Schmandt

The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center

Career Start Year 1991

Number of shared co-authors 0

Joan Albanell

Hospital del Mar Research Institute

Career Start Year 1990

Number of shared co-authors 7

Tanja Pejovic

Oregon Health & Science University

Career Start Year 1989

Number of shared co-authors 2

Emile E Voest

The Netherlands Cancer Institute

Career Start Year 1989

Number of shared co-authors 4

Wei Zhang

The University of Texas MD Anderson Cancer Center

Career Start Year 1988

Number of shared co-authors 2

Silvano Bosari

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Career Start Year 1986

Number of shared co-authors 0

Gottfried E Konecny

David Geffen School of Medicine at University of California Los Angeles

Career Start Year 1984

Number of shared co-authors 2

Olli Kallioniemi

Karolinska Institute

Career Start Year 1984

Number of shared co-authors 2

David D L Bowtell

Peter MacCallum Cancer Centre

Career Start Year 1983

Number of shared co-authors 0

Andrew Berchuck

Duke School of Medicine

Career Start Year 1983

Number of shared co-authors 3

David M Nanus

Sandra and Edward Meyer Cancer Center

Career Start Year 1983

Number of shared co-authors 0

John A Copland

Mayo Clinic Jacksonville

Career Start Year 1982

Number of shared co-authors 0

Edison T Liu

USA The Jackson Laboratory Cancer Center

Career Start Year 1982

Number of shared co-authors 0

Beth Y Karlan

David Geffen School of Medicine, University of California los angeles

Career Start Year 1981

Number of shared co-authors 7

David M Thomas

Garvan Institute of Medical Research

Career Start Year 1980

Number of shared co-authors 0

Fabien Calvo

Universite de Paris-Cite

Career Start Year 1979

Number of shared co-authors 0

Christopher C Benz

Buck Institute for Research on Aging

Career Start Year 1977

Number of shared co-authors 2

Gordon B Mills

Knight Cancer Institute, Oregon Health and Sciences University

Career Start Year 1976

Number of shared co-authors 5

David W Hedley

Princess Margaret Cancer Centre, University Health Network

Career Start Year 1975

Number of shared co-authors 1

Jeffrey S Ross

Foundation Medicine

Career Start Year 1974

Number of shared co-authors 2

Dennis J Slamon

David Geffen School of Medicine at university of california los angeles

Career Start Year 1973

Number of shared co-authors 5

Anna DeFazio

Westmead Hospital

Career Start Year 1972

Number of shared co-authors 2

row(s) 1 - 30 of 30

Kim Benstead

Gloucestershire Hospitals NHS Foundation Trust

Co-authored papers 2

Carolien H M van Deurzen

Erasmus MC Cancer Institute

Co-authored papers 2

John W M Martens

Erasmus Medical Center (MC) Cancer Institute

Co-authored papers 2

Eric P Winer

Dana-Farber Cancer Institute

Co-authored papers 2

Lavinia P Middleton

The University of Texas MD Anderson Cancer Center

Co-authored papers 2

Stefan Aebi

University of Bern

Co-authored papers 2

A E van Leeuwen-Stok

Free University Hospital

Co-authored papers 2

Aleksandra Peric

Co-authored papers 2

Fatima Cardoso

Champalimaud Clinical Center/Champalimaud Foundation

Co-authored papers 2

Jane Bayani

Ontario Institute for Cancer Research

Co-authored papers 2

John M S Bartlett

University of Edinburgh

Co-authored papers 2

Larissa A Korde

Clinical Investigations Branch, National Cancer Institute

Co-authored papers 2

Oliver B??gler

American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University

Co-authored papers 2

Lissandra Dal Lago

Institut Jules Bordet

Co-authored papers 2

Isabel T Rubio

Clinica Universidad de Navarra, Cancer Center Universidad de Navarra

Co-authored papers 2

Ingrid Hedenfalk

Lund University and Skane University Hospital

Co-authored papers 2

Peggy L Porter

Fred Hutchinson Cancer Research Center